Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors
Conditions: Central Nervous System Embryonal Tumor, Not Otherwise Specified; Malignant Glioma; Recurrent Atypical Teratoid/Rhabdoid Tumor; Recurrent Childhood Ependymoma; Recurrent Diffuse Intrinsic Pontine Glioma; Recurrent Medulloblastoma; Refractory Diffuse Intrinsic Ponti ne Glioma Interventions: Drug: Everolimus; Other: Laboratory Biomarker Analysis; Other: Pharmacological Study; Drug: Ribociclib Sponsors: Pediatric Brain Tumor Consortium; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain | Brain Cancers | Brain Tumor | Cancer & Oncology | Children | Embryonal Carcinoma | Ependymoma | Glioma | Medulloblastoma | Neurology | Pediatrics | Study